UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[ASCO 2019] 'Ibrance brings hopes to neglected premenopausal breast cancer patients'
CHICAGO, Ill. -- A Korean study has shown that Pfizer's Ibrance extends...
by Lee Han-soo, KBR Corresponden
|
2019-06-05 11:33
라인
[ASCO 2019]'Belvarafenib confirms efficacy for solid cancer without approved treatment'
CHICAGO, Ill. -- Belvarafenib, developed by Hanmi Pharmaceutical, has demon...
by Lee Han-soo, KBR Correspondent
|
2019-06-05 11:29
라인
FDA OKs phase-1 trial for Yuhan’s investigational lung cancer drug
Yuhan Corp. is gearing up to develop a new lung cancer drug Lazertinib (YH2...
by Jeong Sae-im
|
2019-06-04 14:21
라인
[ASCO 2019] ‘POLO study opens a new era for treating pancreatic cancer patients’
CHICAGO, Ill. -- AstraZeneca and MSD, also known as Merck & Co. inside the ...
by Lee Han-soo, KBR corresponden
|
2019-06-03 16:18
라인
[ASCO 2019]Novartis’ Kisqali aims to make comeback with new trial results
CHICAGO, Ill. -- Novartis Kisqali, a cyclin-dependent kinase (CDK) 4/6 inhi...
by Lee Han-soo, KBR correspondent
|
2019-06-03 13:41
라인
[ASCO 2019]Korea expanding presence in global oncology field
CHICAGO, Ill. -- American Society of Clinical Oncology (ASCO) 2019 kicked o...
by Lee Han-soo, KBR correspondent
|
2019-06-03 11:17
라인
[ASCO 2019]Roche CEO unveils his company’s future direction at ASCO 2019
CHICAGO, Ill. -- Roche Pharmaceuticals is one of is the largest healthcare ...
by Lee Han-soo, KBR correspondent
|
2019-06-03 11:09
라인
[ASCO 2019]'Asia vital region for Roche’
CHICAGO, Ill. -- The American Society of Clinical Oncology (ASCO) is one of...
by Lee Han-soo, KBR correspondent
|
2019-06-03 11:01
라인
Hanmi’s hypertension drug was effective in phase-4 study
Hanmi Pharmaceutical’s new combination drug Amosartan (losartan/amlodipine)...
by Jeong Sae-im
|
2019-05-31 16:05
라인
AbbVie’s chronic lymphocytic leukemia drug wins Korean license
AbbVie Korea said it obtained the Ministry of Food and Drug Safety’s approv...
by Park Gi-taek
|
2019-05-30 15:14
라인
HIV prevention pill to get insurance benefit in Korea
The local medical community is likely to use a drug to prevent HIV infectio...
by Kim Yun-mi
|
2019-05-30 13:25
라인
Daiichi Sankyo to co-promote Daewoong's hypertension treatment
Daiichi Sankyo Korea has signed an agreement with Daewoong to co-promote Ol...
by Lee Han-soo
|
2019-05-29 14:50
라인
‘Enstilum treats all psoriasis from mild to severe ones’
Enstilum Foam (betamethasone dipropionate/calcipotriol), a foam-type treatm...
by Kim Yun-mi
|
2019-05-28 14:44
라인
Indonesia gave nods to Medytox's hyaluronic acid filler
Medytox said Tuesday that it has received sales approval for its Neuramis l...
by Lee Han-soo
|
2019-05-28 14:42
라인
Seoul revokes sales license of Invossa-K, prosecutes Kolon Life Science
The Ministry of Food and Drug Safety has revoked the sales approval for Kol...
by Lee Han-soo
|
2019-05-28 11:31
라인
Corestem applies for FDA meet on Lou Gehrig's drug
Corestem said Monday that it has applied for a pre-investigational new drug...
by Lee Han-soo
|
2019-05-27 17:51
라인
Medytox suspected of GMP violation filed at anti-corruption commission
Medytox, the Korean botulinum toxin maker, is suspected of breaching Good M...
by Jeong Sae-im
|
2019-05-27 15:52
라인
HanAll's global partner starts P2 trial of Graves' ophthalmopathy treatment
Immunovant, HanAll Biopharma's global partner, has begun administering ...
by Lee Han-soo
|
2019-05-24 14:44
라인
OliX confident of its age-related macular degeneration treatment’s efficacy
OliX Pharmaceutical said it plans to submit an investigational new drug app...
by Lee Han-soo
|
2019-05-23 13:48
라인
Sillajen, CHA Hospital to co-develop immunotherapy
Sillajen said Wednesday it has entered an agreement with CHA Bundang Hospit...
by Lee Han-soo
|
2019-05-22 18:26
-
이전
41
42
43
44
45
46
47
48
49
50
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top